Title: Shortage of Estrogen Patches Leaves Menopausal Women in Desperation
Subtitle: Women Struggle to Find Hormone Therapy Medication as Estrogen Patch Supply Remains Unstable
Date: June 19, 2023
In recent news, menopausal women in Norway are facing a significant challenge due to a shortage of estrogen patches. The estrogen patch, known as Estradot, is a transdermal patch that provides estrogen supplementation to women who need it, either due to menopause or other reasons. However, since last autumn, the Norwegian Medicines Agency has reported an unstable supply of Estradot, causing frustration and desperation among women who rely on hormone therapy.
Menopause, a natural phase in a woman’s life, occurs when the ovaries produce less estrogen and progesterone. This hormonal change can lead to various symptoms, including hot flashes, irregular periods, vaginal dryness, decreased sex drive, difficulty sleeping, weight gain, mood swings, and more. While some women experience mild symptoms, others face severe problems that significantly impact their quality of life.
Hormone therapy, such as the use of estrogen patches, has been proven effective in alleviating menopausal symptoms for many women. However, the shortage of Estradot patches has left women like Anne-Beate Stenstøen struggling to secure a supply of estrogen to function both at work and in their personal lives. Stenstøen describes the situation as an “eternal hunt,” constantly visiting pharmacy websites to find the much-needed patches.
Pharmacies across the country are also affected by the shortage, with the supply of estrogen patches becoming sporadic and quickly disappearing from the shelves. Yemi Awoyemi, a pharmacist at Apotek 1 Sfinxen in Oslo, explains that women are going from one pharmacy to another in desperation, but finding a solution is challenging. Without estrogen, women experience a return of their menopausal symptoms, affecting their physical and mental well-being.
The shortage of estrogen patches, including Estradot, has been an ongoing issue for several years, not only in Norway but also throughout Scandinavia and Great Britain. Gynecologist Helena Enger at Volvat Hospital has raised concerns about the lack of estrogen patches and has contacted the pharmaceutical company responsible for production. Enger estimates that one-third of women experience significant problems related to menopause.
The reasons behind the shortage are multifaceted, including global supply problems, limited production capacity, and a complex value chain involving raw materials and packaging from various regions. Sandoz, the company responsible for Estradot, acknowledges the challenges and hopes to resume deliveries in the next few weeks.
The current situation highlights the importance of addressing the needs of menopausal women and ensuring a stable supply of hormone therapy medications. The impact of menopausal symptoms on women’s lives should be treated with the same importance as any other medical condition. Efforts to increase awareness, open discussions, and find solutions to the shortage are crucial to support women’s health and well-being during this phase of life.
As women like Anne-Beate Stenstøen continue their hunt for estrogen patches, it is essential to prioritize their access to hormone therapy and work towards resolving the shortage issue. Menopause should not be a barrier to women’s ability to lead fulfilling lives, both personally and professionally.Title: Shortage of Estrogen Patches Leaves Women in Desperation
Subtitle: Women’s Health Impacted by Global Supply Problems
Date: June 19, 2023
In recent months, a shortage of estrogen patches has left many women in Norway struggling to find the medication they need to manage menopause symptoms. Anne-Beate Stenstøen, a 54-year-old woman experiencing menopause, has been dependent on hormone therapy to function both at work and in her personal life. However, the pharmacy shelves have been consistently empty, forcing her to constantly search online for available estrogen patches.
Menopause, a natural phase in a woman’s life, occurs when the ovaries produce less estrogen and progesterone. This hormonal change can lead to various symptoms, including hot flashes, irregular periods, vaginal dryness, and mood swings. While some women experience mild symptoms, others face severe problems that significantly impact their quality of life. Hormone therapy, such as estrogen patches, can provide relief for these symptoms, but the current shortage has made it difficult for women like Stenstøen to access the medication they need.
The shortage of estrogen patches, particularly the brand Estradot, has been reported by the Norwegian Medicines Agency since last autumn. The supply has been unstable, and pharmacies frequently run out of stock. The situation has become so dire that women are resorting to visiting multiple pharmacies in desperation, only to find disappointment. The lack of estrogen patches not only affects women’s physical well-being but also has a significant impact on their mental health and ability to work.
The pharmaceutical company responsible for Estradot, Sandoz, has acknowledged the global supply problems affecting the production of the patches. The company cites a shortage of raw materials, packaging materials, and a complicated value chain as contributing factors. Additionally, the rising global demand for the product, especially from countries like Great Britain and the United States, has further strained the already limited production capacity.
Sandoz advises patients who cannot access Estradot to consult with their doctors to explore alternative treatments. However, for many women, the shortage of estrogen patches has resulted in worsening symptoms and increased sick leave from work. This not only affects individual women but also has broader implications for women’s health and the social economy.
The current situation highlights the importance of addressing the global supply problems and ensuring consistent access to essential medications for women experiencing menopause. It is crucial to prioritize women’s health and well-being by finding solutions to the shortage of estrogen patches and supporting alternative treatments.
acog menopause hormone therapy
Ntly impact their quality of life.
One of the most effective treatments for menopausal symptoms is hormone therapy, which involves the use of estrogen patches. However, the supply of estrogen patches, particularly Estradot, has been unstable in Norway since last autumn. This shortage has caused frustration and desperation among women who rely on hormone therapy to alleviate their symptoms.
Pharmacies across the country have also been affected by the shortage, with the supply of estrogen patches becoming sporadic and quickly disappearing from the shelves. Women like Anne-Beate Stenstøen are constantly searching for available patches, describing the situation as an “eternal hunt.” Without estrogen, women experience a return of their menopausal symptoms, affecting both their physical and mental well-being.
The shortage of estrogen patches is not limited to Norway; it is an ongoing issue in other Scandinavian countries and Great Britain as well. Gynecologist Helena Enger at Volvat Hospital has raised concerns about the lack of estrogen patches and has contacted the pharmaceutical company responsible for production. She estimates that one-third of women experience significant problems related to menopause.
The reasons behind the shortage are complex, involving global supply problems, limited production capacity, and a complex value chain involving raw materials and packaging from various regions. The pharmaceutical company responsible for Estradot, Sandoz, acknowledges the challenges and hopes to resume deliveries in the next few weeks.
In light of this shortage, it is crucial to prioritize the needs of menopausal women and ensure a stable supply of hormone therapy medications. Menopause should not be a barrier to women’s ability to lead fulfilling lives, both personally and professionally. Efforts to increase awareness, open discussions, and find solutions to the shortage are essential to support women’s health and well-being during this phase of life.
As women like Anne-Beate Stenstøen continue to search for estrogen patches, it is important to advocate for their access to hormone therapy and work towards resolving the shortage issue. Menopausal symptoms can significantly impact women’s lives, and addressing their needs should be treated as a priority.
It’s disheartening to see menopausal women facing yet another obstacle in their journey for relief. The scarcity of estrogen patches further intensifies the frustration of those already grappling with hormonal imbalances. It’s crucial that medical practitioners and manufacturers address this shortage promptly and ensure these essential treatments are readily available to provide much-needed comfort and support to menopausal women.